Inozyme Pharma, Inc. Profile Avatar - Palmy Investing

Inozyme Pharma, Inc.

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a solu…

Biotechnology
US, Boston [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of INZY's Analysis
CIK: 1693011 CUSIP: 45790W108 ISIN: US45790W1080 LEI: - UEI: -
Secondary Listings
INZY has no secondary listings inside our databases.